AVITA Medical (ASX:AVH) Q1 2026 revenue rose 10% sequentially to US$19.3m but cash fell to US$14.3m as a new CEO and BARDA deal reset the story.
15
Skip to content
Skip to sidebar
Skip to footer
Stocks in Spotlight
View all →-
AI Stocks · Semiconductor stocks SanDisk (NASDAQ:SNDK) The Sell Case Behind a 3,300% AI Memory Rally May 21, 2026 -
Financials · Growth Stocks Powerhouse (ASX:PVL) Why the Re-Rate May Only Be Getting Started May 20, 2026
-
